(GBM) is the most prevalent and malignant primary brain tumor and contains
self-renewing, tumorigenic cancer stem cells
(CSCs) that contribute to tumor
initiation and therapeutic resistance. As normal stem and progenitor cells
participate in tissue development and repair, these developmental programs
re-emerge in CSCs to support the development and progressive growth of tumors.